Abstract: The disclosed technology includes a bioabsorbable material configured to be delivered to tissue. The material includes a shape-memory polymer compressible in a delivery configuration and configured to swell within a predetermined period of time. The shape-memory polymer includes one or more functional groups for reversible bonding between adjacent functional groups to transition between an approximately linear polymer and an approximately non-linear polymer upon exposure to a stimulation.

Abstract: The disclosed technology includes a bioabsorbable material configured to be delivered to tissue. The material includes a porous body comprising at least one polymer comprising a first zone comprising a first crosslink density and a second zone comprising a second crosslink density different than the first zone. The first and second zones form a gradient of compression strength along a portion of the porous body.

Abstract: The disclosed technology includes a method for embedding medical additives into a bioabsorbable material. The method may include chemically reacting one or more functional groups of a bioabsorbable material with one or more medical additives. The bioabsorbable material may be configured to be placed inside a body of a human. The one or more medical additives may be configured to remain chemically bonded to a foam structure of the bioabsorbable material until a biodegradation of the bioabsorbable material.

Abstract: The disclosed technology includes a surgical adjunct that includes bioabsorbable material such as a polyurethane foam. A volumetric ratio of the polyurethane foam to the total volume of the surgical adjunct may be in a range of about 0.125 to about 0.325. A glass transition temperature of the surgical adjunct may be about 0° C. to about 40° C.

Abstract: The disclosed technology includes a surgical adjunct includes a polyurethane foam and a film disposed on at least one surface of the polyurethane foam. A volumetric ratio of the polyurethane foam to the total volume of the surgical adjunct 604 is in a range of about 0.125 to about 0.325.

Abstract: The disclosed technology includes a surgical adjunct 604 that includes a polyurethane foam comprising a volumetric ratio of the polyurethane foam to the total volume of the surgical adjunct 604 is in a range of about 0.125 to about 0.325, and at least one hydrophobicity additive comprising at least one ceramic nanoparticle, at least one fatty acid, at least one ionic liquid, at least one long chain surfactant, at least one enteric coating, at least one photocurable resin, or combinations thereof.

Abstract: Technologies are described for a distributed audio system configured to switch operating modes. In some examples, the distributed audio system may include a device configured to execute first instructions from a first memory corresponding to operation in a first mode, receive a signal to switch modes, and, responsive to receiving the signal, switch a select signal corresponding to the first memory to select a second memory. Responsive to selecting the second memory, the device may be configured to execute second instructions from the second memory corresponding to operation in a second mode. The device may enter a registration mode to register portable parts to the device.

Abstract: Technologies are described for a distributed audio system configured to switch operating modes. In some examples, the distributed audio system may include a device configured to execute first instructions from a first memory corresponding to operation in a first mode, receive a signal to switch modes, and, responsive to receiving the signal, switch a select signal corresponding to the first memory to select a second memory. Responsive to selecting the second memory, the device may be configured to execute second instructions from the second memory corresponding to operation in a second mode. The device may enter a registration mode to register portable parts to the device.

Abstract: A material handling bucket apparatus including a material handling bucket and method of use thereof. The material handling bucket includes a bucket back half and a bucket front half. The bucket back half is configured to engage a loader. The bucket back half includes a plurality of guide slots and a dozer scraping lip configured to engage a surface. The bucket front half is pivotally coupled to the bucket back half. The bucket front half includes a plurality of slide members receivable in the plurality of guide slots. The plurality of slide members are configured to slide within the plurality of guide slots to allow the bucket front half to move linearly and pivotally relative to the bucket back half.

Abstract: Devices for intranasal administration of naloxone are disclosed. The devices comprise a foam applicator and are configured to locate an applicator comprising a naloxone composition, in proximity to the middle turbinate and/or inferior turbinate. Naloxone can be delivered to the nasal mucosa by squeezing the nostril against the applicator. The device and methods of using the devices can be used to treat an opioid overdose.

Abstract: Methods are provided for the synthesis of a compound of formula (X). R2 is selected from —H, —C1-C4-alkyl, —C2-C4-alkenyl and C1-C4-aryl; R3 is selected from —C(O)H and —C(O)C1-C4-alkyl; and A is a pharmaceutically acceptable anion (e.g. a halide). Also provided are intermediate compounds formed during the synthesis.

Abstract: A screed system includes a screed plate and a plurality of pressure sensors coupled to the screed plate and configured to sense a weight of the screed plate. A method for positioning screed system includes receiving pressure information from a plurality of pressure sensors engaged with a screed plate; determining a pressure distribution across the screed plate based on the pressure information; determining, based on the determined pressure distribution across the screed plate, an angle of attack of the screed plate; and adjusting the angle of attack of the screed plate.

Abstract: Devices for intranasal administration of naloxone are disclosed. The devices comprise a foam applicator and are configured to locate an applicator comprising a naloxone composition. in proximity to the middle turbinate and/or inferior turbinate. Naloxone can be delivered to the nasal mucosa by squeezing the nostril against the applicator. The device and methods of using the devices can be used to treat an opioid overdose.

Abstract: A screed system includes a screed plate and a plurality of pressure sensors coupled to the screed plate and configured to sense a weight of the screed plate. A method for positioning screed system includes receiving pressure information from a plurality of pressure sensors engaged with a screed plate; determining a pressure distribution across the screed plate based on the pressure information; determining, based on the determined pressure distribution across the screed plate, an angle of attack of the screed plate; and adjusting the angle of attack of the screed plate.

Abstract: The modular screed plate assembly and method has a road paver/finisher, a structural/conductor plate and modular screed plates. The road paver/finisher has a paver under side, a power source and a heating element, for heating the modular screed plates. The modular screed plates have coupling elements, and retainer quick-connect/releases, and align as a modular screed plate array, providing a tensionally yielding gap allowing the modular screed plate array to absorb pressures from paving operations. The structural/conductor plate couples with the coupling elements and has screed plate retaining locks to securely receives the retainer quick-connect/releases, in order to secure itself to the modular screed plates. The structural/conductor plate receives heat directly from the heating element, and provides indirect heat to the modular screed plate array.